Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HLS8
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0016791 | phosphatase activity | 5 | 12 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 12 |
GO:0003993 | acid phosphatase activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.292 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.449 |
DEG_APCC_DBOX_1 | 66 | 74 | PF00400 | 0.298 |
DEG_SPOP_SBC_1 | 85 | 89 | PF00917 | 0.298 |
DOC_CKS1_1 | 28 | 33 | PF01111 | 0.445 |
DOC_MAPK_MEF2A_6 | 55 | 62 | PF00069 | 0.439 |
DOC_PP1_RVXF_1 | 16 | 23 | PF00149 | 0.314 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.445 |
DOC_USP7_MATH_1 | 196 | 200 | PF00917 | 0.561 |
DOC_USP7_MATH_1 | 74 | 78 | PF00917 | 0.192 |
DOC_USP7_MATH_1 | 85 | 89 | PF00917 | 0.297 |
DOC_WW_Pin1_4 | 27 | 32 | PF00397 | 0.370 |
DOC_WW_Pin1_4 | 37 | 42 | PF00397 | 0.337 |
LIG_14-3-3_CanoR_1 | 169 | 178 | PF00244 | 0.192 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.714 |
LIG_CSL_BTD_1 | 28 | 31 | PF09270 | 0.383 |
LIG_FHA_1 | 87 | 93 | PF00498 | 0.418 |
LIG_FHA_2 | 102 | 108 | PF00498 | 0.234 |
LIG_GBD_Chelix_1 | 20 | 28 | PF00786 | 0.298 |
LIG_LIR_Apic_2 | 173 | 178 | PF02991 | 0.461 |
LIG_LIR_Gen_1 | 149 | 157 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 82 | 86 | PF02991 | 0.371 |
LIG_Pex14_1 | 79 | 83 | PF04695 | 0.383 |
LIG_SH2_STAP1 | 151 | 155 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.314 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.383 |
LIG_SH3_2 | 41 | 46 | PF14604 | 0.418 |
LIG_SH3_3 | 38 | 44 | PF00018 | 0.374 |
LIG_SH3_4 | 43 | 50 | PF00018 | 0.445 |
MOD_CDC14_SPxK_1 | 40 | 43 | PF00782 | 0.398 |
MOD_CDK_SPxK_1 | 37 | 43 | PF00069 | 0.404 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.657 |
MOD_CK2_1 | 144 | 150 | PF00069 | 0.418 |
MOD_CK2_1 | 53 | 59 | PF00069 | 0.445 |
MOD_GlcNHglycan | 54 | 58 | PF01048 | 0.423 |
MOD_N-GLC_1 | 158 | 163 | PF02516 | 0.314 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.297 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.314 |
MOD_Plk_4 | 24 | 30 | PF00069 | 0.225 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.413 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.356 |
MOD_ProDKin_1 | 27 | 33 | PF00069 | 0.370 |
MOD_ProDKin_1 | 37 | 43 | PF00069 | 0.337 |
TRG_DiLeu_BaLyEn_6 | 58 | 63 | PF01217 | 0.383 |
TRG_ENDOCYTIC_2 | 151 | 154 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.383 |
TRG_Pf-PMV_PEXEL_1 | 61 | 65 | PF00026 | 0.308 |
TRG_PTS1 | 198 | 201 | PF00515 | 0.626 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I5R9 | Leptomonas seymouri | 68% | 100% |
A0A0S4J859 | Bodo saltans | 45% | 100% |
A0A1X0P3P5 | Trypanosomatidae | 56% | 99% |
A0A3Q8IDV7 | Leishmania donovani | 83% | 100% |
A0A3S5IR86 | Trypanosoma rangeli | 58% | 100% |
A4I987 | Leishmania infantum | 84% | 100% |
D0A698 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 59% | 100% |
E9B454 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
O94279 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 30% | 100% |
Q86V88 | Homo sapiens | 30% | 100% |
Q9D967 | Mus musculus | 30% | 100% |
Q9GRN1 | Leishmania major | 84% | 100% |
V5B8Q4 | Trypanosoma cruzi | 56% | 81% |